Literature DB >> 28428227

MECHANISMS IN ENDOCRINOLOGY: The multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation.

Manuel H Aguiar-Oliveira1, Anita H O Souza1, Carla R P Oliveira1, Viviane C Campos1, Luíz A Oliveira-Neto1, Roberto Salvatori2.   

Abstract

Twenty years ago, we described kindred of 105 individuals with isolated GH deficiency (IGHD) in Itabaianinha County, in northeast Brazil, carrying a homozygous mutation in the GH-releasing hormone receptor gene. These subjects exhibit markedly reduced GH responsiveness to stimulatory tests, and anterior pituitary hypoplasia. Serum concentrations of IGF-I, IGF binding protein type 3 and the acid-labile subunit are markedly reduced, with a lesser reduction of IGF-II. The most striking physical findings of these IGHD individuals are the proportionate short stature, doll facies, high-pitched voice and visceral obesity with reduced fat-free mass. There is neither microphallus, nor neonatal hypoglycemia. Puberty is delayed, menopause anticipated, but fertility is preserved in both genders. The reduction in bone sizes is not even, with mean standard deviation scores for height of -7.2, total maxillary length of -6.5, total facial height of -4.3 and cephalic perimeter of -2.7. In addition, the non-osseous growth is not uniform, preserving some organs, like pancreas, liver, kidney, brain and eyes, and compromising others such as thyroid, heart, uterus and spleen. These subjects present higher prevalence of dizziness, mild high-tones sensorineural hearing loss, reduction of vascular retinal branching points, increase of optic disk, genu valgum and increased systolic blood pressure. Biochemically, they have high low density lipoprotein cholesterol and C-reactive protein levels, but maintain increased insulin sensitivity, and do not show premature atherosclerosis. Finally, they have normal immune function, and normal longevity. This review details the findings and summarizes 20 years of clinical research carried out in this unique population.
© 2017 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28428227     DOI: 10.1530/EJE-16-1047

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  18 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Sweat and vitamin D status in congenital, lifetime, untreated GH deficiency.

Authors:  Cynthia S Barros-Oliveira; Roberto Salvatori; Jéssica S S Dos Santos; Paula F C Santos; Alécia A Oliveira-Santos; Cindi G Marinho; Elenilde G Santos; Ângela C G B Leal; Viviane C Campos; Nayra P Damascena; Carla R P Oliveira; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2019-07-10       Impact factor: 3.633

Review 3.  Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.

Authors:  Xin He; Ariel L Barkan
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

4.  Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function.

Authors:  Alana L Andrade-Guimarães; Manuel H Aguiar-Oliveira; Roberto Salvatori; Vitor O Carvalho; Fabiano Alvim-Pereira; Carlos R Araújo Daniel; Giulliani A Moreira Brasileiro; Ananda A Santana-Ribeiro; Hugo A Santos-Carvalho; Carla R P Oliveira; Edgar R Vieira; Miburge B Gois-Junior
Journal:  Endocrine       Date:  2018-09-24       Impact factor: 3.633

5.  Cerebral vasoreactivity, a surrogate marker of cerebrovascular disease, is not impaired in subjects with lifetime, untreated, congenital isolated GH deficiency.

Authors:  Cindi G Marinho; Hyder A Melo; Roberto Salvatori; Marco A P Nunes; Carla R P Oliveira; Viviane C Campos; Cynthia S Barros-Oliveira; Alécia A Oliveira-Santos; Nelmo V Menezes; Hertz T Santos-Júnior; Elenilde G Santos; Manuela A Melo; Joselina L M Oliveira; Enaldo V Melo; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2020-07-12       Impact factor: 3.633

Review 6.  Growth Hormone and Aging: New Findings.

Authors:  Andrzej Bartke; Erin Hascup; Kevin Hascup; Michal M Masternak
Journal:  World J Mens Health       Date:  2021-02-03       Impact factor: 5.400

7.  Benefits of Living Without Growth Hormone.

Authors:  Andrzej Bartke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.591

Review 8.  Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome.

Authors:  Manuel H Aguiar-Oliveira; Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2020-09-16       Impact factor: 6.514

9.  [Hormonal influence on hearing].

Authors:  J M Vahl; E Goldberg-Bockhorn; T K Hoffmann; M C Wigand
Journal:  HNO       Date:  2021-03-16       Impact factor: 1.284

Review 10.  Individual sensitivity to growth hormone replacement in adults.

Authors:  Cesar Luiz Boguszewski
Journal:  Rev Endocr Metab Disord       Date:  2020-10-07       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.